Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Convertible Debt: 2017-2020

Historic Convertible Debt for Neurocrine Biosciences (NBIX) over the last 4 years, with Dec 2020 value amounting to $317.9 million.

  • Neurocrine Biosciences' Convertible Debt was N/A to $330.7 million in Q3 2021 from the same period last year, while for Sep 2021 it was $330.7 million, marking a year-over-year change of. This contributed to the annual value of $317.9 million for FY2020, which is 22.24% down from last year.
  • Per Neurocrine Biosciences' latest filing, its Convertible Debt stood at $317.9 million for FY2020, which was down 22.24% from $408.8 million recorded in FY2019.
  • Neurocrine Biosciences' 5-year Convertible Debt high stood at $408.8 million for FY2019, and its period low was $317.9 million during FY2020.
  • For the 3-year period, Neurocrine Biosciences' Convertible Debt averaged around $371.7 million, with its median value being $388.5 million (2018).
  • Per our database at Business Quant, Neurocrine Biosciences' Convertible Debt rose by 5.23% in 2019 and then decreased by 22.24% in 2020.
  • Over the past 4 years, Neurocrine Biosciences' Convertible Debt (Yearly) stood at $369.6 million in 2017, then climbed by 5.11% to $388.5 million in 2018, then grew by 5.23% to $408.8 million in 2019, then dropped by 22.24% to $317.9 million in 2020.